The U.S. Food and Drug Administration has approved the marketing of a new tool that can test a person’s blood to diagnose ...

The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith ...

A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...

A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This ...

Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years' accumulated experience in the ...

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

The FDA’s approval of Fujirebio’s ‘Lumipulse G' can now be used by doctors to determine whether or not someone has a build-up ...

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

There is a new advance in the detection of Alzheimer’s disease. A blood test that can detect Alzheimer’s disease was approved ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.

The test allows for much earlier detection of the disease, even before clear memory or behavioural symptoms appear ...